Researchers told 1,880 people over 70 to either stop or keep taking their statins. Stopping looked safe at two years, but one number shifted after that
Millions of people over 70 take a statin every day to prevent a first heart attack or stroke, often for decades, even though the big trials behind these drugs rarely included people that old. Many of them wonder whether they can stop. A team led by the University of Bern answered that the only reliable way: they randomly assigned 1,880 adults aged 70 and older to either stop their statin or keep taking it, and followed them for up to four years.
At two years, stopping passed the test the trial was designed for. The rate of heart attacks, strokes and deaths was not meaningfully worse in people who quit than in people who stayed on the drug, within the margin the researchers had set in advance.
But the gap kept growing. Over the full follow-up, 12.7% of people who stopped had a heart attack, a stroke or died (119 of 938), compared with 9.2% of those who continued (87 of 942). That is a 38% higher rate, or roughly one extra serious event for every 40 people who stopped within two years.
And stopping did not buy the benefit many people hope for. Quality of life, muscle pain, falls and muscle loss were about the same in both groups.
The trial, called STREAM, was published in The New England Journal of Medicine and presented at the American Heart Association’s Scientific Sessions in Chicago. It ran at 24 medical centers in Switzerland, the Netherlands and France.
Everyone in it was taking a statin for primary prevention, meaning they had never had a heart attack, stroke or other diagnosed cardiovascular disease. All had at least two chronic conditions, such as diabetes, a history of cancer or lung disease. Their average age was 77.5, and 46.9% were women. About a third had diabetes.
The two-year numbers show where the extra events came from. Heart attacks occurred in 1.4% of people who stopped versus 0.6% who continued, and ischemic strokes in 1.9% versus 0.8%. Deaths from any cause were 8.2% versus 6.9%.
In a subset of participants who had their blood checked after a year, LDL cholesterol in the stopping group had climbed to an average of 176 mg/dL, compared with about 99 mg/dL in people still on the drug.
“This small, increased risk of cardiovascular events means that one cannot make a general recommendation about stopping statins in this patient population,” said study author Rita Redberg, a cardiology professor at the University of California, San Francisco.
“There should be shared decision-making between the patient and the healthcare professional,” she added.
Redberg noted that earlier studies had found no difference in deaths when adults over 70 stopped statins, and one had suggested quality of life improved. A French trial of older adults published earlier this year in The Lancet Healthy Longevity also found stopping did not raise the death rate over three years. But the people in that trial were healthier, and STREAM is larger and tracked heart attacks and strokes separately.
After the trial ended, its independent safety board recommended that people in the stopping group talk to their doctors about restarting.
Long-term prescriptions are a recurring question for older adults. We recently looked at which antidepressants hold up best over the long term, and at what actually tracks heart health in a study of the molecule behind NAD supplements.
If you are over 70 and take a statin, the practical message is not to stop on your own. Bring it up with your doctor, especially if you have side effects, and weigh the small added risk against your own health, priorities and life expectancy.
There are limits. The trial was open-label, so participants knew whether they were taking a statin, and there was no placebo. About 14% of people switched from their assigned group, although extra analyses found this did not change the conclusions. The results apply to people over 70 with several chronic conditions and no heart disease, not to people who have already had a heart attack or stroke.
Source
Rodondi N, Haller ML, Bardoczi JB, et al. “Discontinuing statins in older adults without cardiovascular disease.” The New England Journal of Medicine, 2026.
DOI: 10.1056/NEJMoa2606634